Olivia Gennarelli
Nurse Practitioner · Gulfport, MSNPI 1124709126
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,317 of the $5,295 with a category attached, or 81.5%. It is spread thinly across 35 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,464, 6.5 times the $381 reported in 2023. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $31.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$937
- Johnson & Johnson$626
- Exelixis Inc.$569
- AstraZeneca$499
- Merck$393
- Takeda Pharmaceuticals U.S.A., Inc.$229
- plus $2K from 29 others
What the payments were for
- Consulting fees$75014%
- Food & beverage$4,31782%
- Education$2294%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $937 |
| Johnson & Johnson | 20 | $626 |
| Exelixis Inc. | 9 | $569 |
| AstraZeneca(2 entities) | 14 | $499 |
| Merck | 18 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $229 |
| Bayer | 10 | $224 |
| Pharmaessentia USA Corporation | 7 | $189 |
| Novartis | 7 | $171 |
| Ipsen Biopharmaceuticals, Inc | 7 | $155 |
| Eisai Inc. | 6 | $123 |
| AbbVie | 4 | $116 |
| Gilead | 1 | $111 |
| Astellas Pharma US Inc | 5 | $105 |
| Incyte Corporation | 5 | $94 |
| Pfizer | 4 | $89 |
| Adaptive Biotechnologies Corporation | 3 | $82 |
| Genentech USA, Inc. | 3 | $78 |
| Genmab U.S., Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $65 |
| Boehringer Ingelheim | 2 | $46 |
| Caris MPI, Inc. | 2 | $38 |
| Beone Medicines USA, Inc. | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| GSK | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Recordati_rare_diseases_inc. | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Novocure Inc. | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $16 |
| Stemline Therapeutics Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Beigene USA, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,295 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $11,087 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $653 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $633 |
| Duloxetine Hcl | 28 | $549 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $517 |
| Oxycodone Hcl | 22 | $511 |
| Dexamethasone | 19 | $446 |
| Ondansetron Hcl | 26 | $436 |
| Hydroxyurea | 12 | $273 |
| Potassium Chloride | 16 | $217 |
| Olanzapine | 24 | $202 |
| Ondansetron OdtOndansetron | 12 | $193 |
| Levothyroxine Sodium | 26 | $140 |
| Lactulose | 13 | $105 |
| Gabapentin | 18 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $89 | $11,08717 claims |
| Lilly USA, LLCOlanzapine | $65 | $20224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Gulfport
- Mariah CoxGulfport$14K
- Brittany HicksGulfport$14K
- Robin AllenGulfport$6K
- Michelle StewartGulfport$6K
- Jared DeloachGulfport$6K
- Brenda WakhamGulfport$5K
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.